🧬 777 (@Biotech777) profile picture

the simpler. the better. I mostly tweet about $AFMD

Joined October 2018
Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)Photo by 🧬 777 (@Biotech777)
cc @Roche @genentech You have on your hand the validated @affimed ICE’s science and you have the chance to be ahead of your competitors. But you need to buy them out, they need your knowledge/competence.
3
8
1,055
🧬 777 retweeted
Replying to @graham74GC
Thanks to german managers incompetence at @affimed, this (and other) asset is on sale through the german insolvency rules. $AFMD $AFMDQ
2
3
10
980
$AFMD when you’ll buy biotech, please be careful: - stop buying if it is based in germany; - stop buying if they have these managers: - Adi Hoess - Denise Mueller - Angus Smith - Shawn Leland - Harry Welten (Pls, check the BoD members as well on the 20-F) Thank me later.
3
3
16
1,257
.@affimed management showed to the world how poor they are in managing companies. Horrible spot for german biotechs. Never again. $AFMD
1
1
8
2,181
$AFMD lost faith for those morons at Affimed. New CEO has same charisma of previous one: a total useful idiot for the BoD. They eroded billions from investors. They clearly dont know where the hell are going to. They never had any idea. Never again a German biotech company.
2
14
3,540
$AFMD trading at 0,15$ pre reverse split. This company is managed by SHAMELESS and INCOMPETENT management and directors. They should cut their salaries at the same % market cut their stock (ie 95%).
3
1
10
1,699
Good to know someone with probably deeper knowledge than us is buying despite risk of a (stupid) imminent offering. Maybe Shawn is ready to turn this ship and surprise old destroyed shareholders to be remembered as an hero $AFMD @affimed
$AFMD We know today that 683 was the buyer of these 270k stocks ( cross)
1
2
11
2,528
$AFMD hire a financial advisor and sell this company. ASAP. @affimed … even at 30$. Shareholders are fed up with this ineptness and greed. Vote NO.
$AFMD Hey @affimed Im going to tell you how to do: 1. Call Roche first. In the meanwhile engage a financial advisor to inquire as to whether there would be an interest in potentially making a investment in Affimed by BPs; 2. Give Affimed a fair value based on current data 1/..
1
3
1,278
$AFMD Hey @affimed Im going to tell you how to do: 1. Call Roche first. In the meanwhile engage a financial advisor to inquire as to whether there would be an interest in potentially making a investment in Affimed by BPs; 2. Give Affimed a fair value based on current data 1/..
1
93
.@affimed you are still trading at 0,385 pre reverse split (from 11$). No EV. Care to explain to @lelandspharmd the urgency to make a deal? Better if it is an equity investment by the BP which will be buying you out. No reason to sell the rights of single assets. Sell the whole.
1
1
8
316
$AFMD digest the news … talk with analysts/tutes and let the price goes around 50$ first. Then offer small amount of shares to tutes (pipe) or big pharma. Then drop the stellar data. Then sell the co. cc @lelandspharmd
2
11
847
$AFMD maybe they could get 9 CRs (75%) even at lowest dose level #acimtamig. Will FDA AA this drug?
Replying to @RNA_Biotech
Highest dose levels will give 100% ORR $AFMD
2
2
12
2,209
$AFMD so they are telling us that 13 will be accelerated approved soon and 28 will be a blockbuster but no one is willing to buy them out? Any competent financial advisor please want help them find a buyer before they definitively ruin this company and its science? @affimed
1
2
1
11
1,990
Trading for 0,38$ … @lelandspharmd better be cooking something special for this broken company. @affimed … in 20 years they have not been able to increase $1 million in value, same value of the IPO. They just killed shareholders. Wake fucking up, you work for investors! $AFMD
2
8
832
.@lelandspharmd AFMD needs a new focused, strong CEO able to finally increase SHs value after ages of disastrous Adi Hoess. Co. has three clinically validated assets: do not destroy value with dilutions, do not offer to friendly-funds. Sale the co. like Trillium did with Pfizer.
3
8
257
cc $AFMD @affimed hurry up guys, competition is coming …
1/#China $BGNE BeiGene has registered its MUC1/CD16A bispecific antibody BGB-B3227 clinicaltrials.gov/study/NCT…. The clinical trial, which will involve either monotherapy or combination therapy with a PD-1 antibody for various solid tumors, is expected to start in 2028.
1
1
7
1,665
Cord blood cells NK expanded using IL-2/IL-15 & EBV-transformed B-feeder cells combined with mAbs (CD20/CD19) w/ engineered Pin mutations to increase affinity for CD16a confers long-term selective cytotoxicity function @JessyPresumey jitc.bmj.com/content/12/7/e0…
1
7
1,370
.@Affimed c’mon Andreas, you can do it! $AFMD $TRIL
2
2
11
1,259
Seriously guys @affimed … what are you doing? $AFMD
$AFMD Hey @affimed Im going to tell you how to do: 1. Call Roche first. In the meanwhile engage a financial advisor to inquire as to whether there would be an interest in potentially making a investment in Affimed by BPs; 2. Give Affimed a fair value based on current data 1/..
2
7
1,671
$AFMD what could AFM24 + Atezo do when tested first lines? $RHHBY $ROG $MRK $PFE
1
6
966
$AFMD Hey @affimed can you hear us? You got your votes. Denise, Andreas, Annalise, W-A-K-E U-P !
1
2
6
877